KR20190079899A - Jellied food with Immune Enhancing Effect Containing Soy Milk and Lactic Acid Bacteria and Its Preparation Method - Google Patents
Jellied food with Immune Enhancing Effect Containing Soy Milk and Lactic Acid Bacteria and Its Preparation Method Download PDFInfo
- Publication number
- KR20190079899A KR20190079899A KR1020170181976A KR20170181976A KR20190079899A KR 20190079899 A KR20190079899 A KR 20190079899A KR 1020170181976 A KR1020170181976 A KR 1020170181976A KR 20170181976 A KR20170181976 A KR 20170181976A KR 20190079899 A KR20190079899 A KR 20190079899A
- Authority
- KR
- South Korea
- Prior art keywords
- lactic acid
- acid bacteria
- soybean milk
- soy milk
- soybean
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 134
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 67
- 241000894006 Bacteria Species 0.000 title claims abstract description 61
- 239000004310 lactic acid Substances 0.000 title claims abstract description 56
- 235000013322 soy milk Nutrition 0.000 title claims abstract description 37
- 235000013305 food Nutrition 0.000 title abstract description 10
- 230000002708 enhancing effect Effects 0.000 title abstract description 6
- 238000002360 preparation method Methods 0.000 title description 3
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 80
- 244000068988 Glycine max Species 0.000 claims abstract description 78
- 239000008267 milk Substances 0.000 claims description 57
- 210000004080 milk Anatomy 0.000 claims description 57
- 235000013336 milk Nutrition 0.000 claims description 46
- 235000015110 jellies Nutrition 0.000 claims description 28
- 239000008274 jelly Substances 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000008213 purified water Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 239000006041 probiotic Substances 0.000 abstract description 8
- 235000018291 probiotics Nutrition 0.000 abstract description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000000529 probiotic effect Effects 0.000 abstract 2
- 230000000694 effects Effects 0.000 description 20
- 102000003945 NF-kappa B Human genes 0.000 description 15
- 108010057466 NF-kappa B Proteins 0.000 description 15
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 14
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 14
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 210000001616 monocyte Anatomy 0.000 description 10
- 238000002835 absorbance Methods 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 235000012424 soybean oil Nutrition 0.000 description 7
- 239000003549 soybean oil Substances 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 6
- 230000010632 Transcription Factor Activity Effects 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000019698 starch Nutrition 0.000 description 6
- 239000008107 starch Substances 0.000 description 6
- 230000036039 immunity Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- 108090000695 Cytokines Proteins 0.000 description 4
- 229920000715 Mucilage Polymers 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000019722 synbiotics Nutrition 0.000 description 4
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 235000013406 prebiotics Nutrition 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000002753 trypsin inhibitor Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 241000237502 Ostreidae Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000086363 Pterocarpus indicus Species 0.000 description 2
- 235000009984 Pterocarpus indicus Nutrition 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 101710162629 Trypsin inhibitor Proteins 0.000 description 2
- 229940122618 Trypsin inhibitor Drugs 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 230000002519 immonomodulatory effect Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000005087 mononuclear cell Anatomy 0.000 description 2
- 235000020636 oyster Nutrition 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- LZDKZFUFMNSQCJ-UHFFFAOYSA-N 1,2-diethoxyethane Chemical compound CCOCCOCC LZDKZFUFMNSQCJ-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 101710102211 11S globulin Proteins 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 101710190853 Cruciferin Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101000937129 Drosophila melanogaster Cadherin-related tumor suppressor Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 208000017170 Lipid metabolism disease Diseases 0.000 description 1
- 208000003445 Mouth Neoplasms Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004159 Potassium persulphate Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000269821 Scombridae Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000004957 immunoregulator effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical group C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000020640 mackerel Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000013777 protein digestion Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013597 soy food Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/40—Pulse curds
- A23L11/45—Soy bean curds, e.g. tofu
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/05—Mashed or comminuted pulses or legumes; Products made therefrom
- A23L11/07—Soya beans, e.g. oil-extracted soya bean flakes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L25/00—Food consisting mainly of nutmeat or seeds; Preparation or treatment thereof
- A23L25/30—Mashed or comminuted products, e.g. pulp, pastes, meal, powders; Products made therefrom, e.g. blocks, flakes, snacks; Liquid or semi-liquid products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/5118—Starch
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Microbiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Beans For Foods Or Fodder (AREA)
Abstract
Description
본 발명은 두유와 유산균을 함유한 면역강화 효능의 묵 및 그 제조방법에 관한 것으로 친환경 콩에서 가공한 두유와 프로바이오틱스 효능의 유산균을 이용하여 올방개 전분으로 전통적인 식품에 면역강화 효능이 있는 묵 및 그 제조방법에 관한 것이다.The present invention relates to a mucilage of immunity-enhancing effect containing soybean milk and lactic acid bacteria and a method for producing the same. The present invention relates to a mucilus which has immunity-enhancing effect on a conventional food by using an extract of soybean oil and probiotics- ≪ / RTI >
전분식품인 쌀을 주식으로 하는 우리에게 쌀에 부족한 단백질과 지질을 보완 공급하는 역할을 담당해 온 대두의 재배는 4천년 전으로 거슬러 올라가며, 재배지는 한반도와 인접하고 있는 중국의 동북부 일대로 추정되고 있다. 대두는 영양분을 자가 공급하는 식물로써 시비를 하지 않아도 척박한 토양에서 잘 자라기 때문에 우리나라에서 널리 재배되었다. 5세기 중엽부터 콩 식품은 심장, 간, 신장, 위장, 결장의 정상 기능 회복을 위한 치료에 이용되었으며, 본초강목에는 콩이 부종이나 신장질환, 중독에 효과가 있는 것으로 기록되어 있다. 콩의 주성분은 단백질로 35~40% 함유되어 있고 다음으로 유지를 15~20% 함유하고 있는데 이 중 80% 이상 불포화지방산으로 콜레스테롤 저하 및 각종 심혈관계 질환 예방에 효과적이다. 최근 들어 콩 및 콩 가공식품이 주목받는 이유는 일반 성분 이외에도 다양한 기능성 성분을 포함하고 있기 때문인데 밝혀진 대표적인 기능성 성분으로는 여성 호르몬인 estrogen과 구조적으로 유사한 항암효과 및 고혈압, 동맥경화 등 순환기 질환, 골다공증에 효과가 있는 이소플라본이 있다. 또한 사포닌은 항암 및 노화 방지에 효과적이고, phytic acid는 인체에 해로운 중금속 이온들과 용이하게 결합하여 체외로 쉽게 배설하는 기능이 있으며 이외에도 trypsin inhibitor, hemaglutinin, 올리고당 등이 콩에 함유된 생리활성 물질로 알려져 있다.Soybean cultivation, which has served as a complementary supply of protein and lipid deficient in rice to starchy rice, is estimated to date back to 4,000 years ago, and the cultivation area is estimated to be the northeastern part of China adjacent to the Korean peninsula . Soybeans are nutritionally self-supporting plants that grow well in poor soil without fertilization and are widely grown in Korea. From the middle of the 5th century, soy foods were used to treat normal function of the heart, liver, kidneys, stomach and colon. In the main stem, soybeans are reported to be effective for edema, kidney disease and poisoning. The main component of soybean contains 35 ~ 40% of protein, followed by 15 ~ 20% of fat, 80% or more of which is unsaturated fatty acid, which is effective in lowering cholesterol and preventing various cardiovascular diseases. Recently, soybean and bean processed foods are attracting attention because they contain various functional ingredients besides general ingredients. Representative functional ingredients revealed include anticancer effects structurally similar to estrogen, a female hormone, circulatory diseases such as hypertension and atherosclerosis, osteoporosis There is isoflavone that is effective in. In addition, saponin is effective for anti-cancer and anti-aging, and phytic acid easily binds to heavy metal ions harmful to human body and excretes easily in vitro. In addition, trypsin inhibitor, hemaglutinin and oligosaccharide are physiologically active substances contained in soy It is known.
이처럼 대두는 단백질 지방의 영양공급원 뿐 아니라 여러 기능성 물질을 함유함으로써 영양학적으로 가치가 있지만, 조직이 견고하여 소화 흡수가 매우 어렵다. 또한 풋내와 소화가 잘되지 않는 탄수화물 트립신 저해제 등의 생리적인 저해 물질로 인하여 가공처리가 잘못될 경우 소화흡수에 문제가 발생하여 설사 등의 부작용을 유발할 수 있다.Soybean is nutritionally valuable as it contains nutrient sources of protein fat as well as various functional substances, but its structure is strong and digestion and absorption are very difficult. Also, due to physiological inhibitory substances such as carbohydrate trypsin inhibitor, which is not well absorbed in the foot and digestion, if the processing is done in a wrong way, digestion and absorption problems may occur, which may cause side effects such as diarrhea.
콩에서 콩물을 추출해서 부드럽게 마실 수 있도록 가공한 두유는 비슷한 칼로리를 가지나 성분조성에서 약간의 차이로 인해 서로 다른 생리적 기능성을 가진다. 두유가 우유보다 영양학적으로 우수한 점은 탄수화물 조성면에서 두유는 난소화성 성분인 콩 올리고당을 함유하고 있어 장내 유익균인 Bifidus 균의 증식에 의한 정장 효과가 있다. 식이섬유는 암, 심장, 간장의 질환과 관련되는 고지혈증 및 알레르기 예방에 간접적으로 관여하고 변비와 대장암에 효과가 있는 것으로 밝혀졌다.Soymilk which has been extracted from beans and processed to soften it has similar calories but has different physiological functions due to slight difference in composition. The nutritional superiority of soy milk compared to milk is that the soy milk contains soy oligosaccharide, which is an indigestible ingredient, in the carbohydrate composition, so that it has a dressing effect due to the proliferation of Bifidus bacteria, which are beneficial bacteria in the intestines. Dietary fiber is indirectly involved in the prevention of hyperlipidemia and allergy associated with cancer, heart and liver diseases, and has been shown to be effective in constipation and colorectal cancer.
두유는 지질성분의 조성에 있어서 우유에 비해 우수한데 단일불포화 지방산과 다 불포화 지방산이 약 70%로 불포화 지방산의 비율이 매우 높은 것으로 알려져 있다. 특히 고도 불포화 지방산 중에는 심장병의 예방효과 및 항암특성을 갖는 δ-3 계열의 α-linolenicacid가 6% 정도 함유되어 있으며 식물성 소재인 콩을 소재로 만들어졌기 때문에 우유와 달리 콜레스테롤이 전혀 없다. 또한 노인성치매의 예방, 콜레스테롤과 중성지질의 감소, 간장, 지질 대사장애의 개선 효과가 있는 인지질(레시틴)이 두유에 상대적으로 많이 함유되어 있다. 단백질은 11S globulin이 주요 구성단백질이며, 콩 속에 함유된 단백질 소화를 억제하는 trypsin 저해재 중 Bowman-Brik형은 Kunitz형과 달리 열에 비교적 안정하여 가공 중 활성을 유지하며, 정상세포가 암세포로 전환하는데 필요한 protease를 저해함으로써 대장암 치료 및 유방암과 구강암의 억제활성을 갖는다.Soy milk is superior to milk in lipid composition. It is known that monounsaturated fatty acid and polyunsaturated fatty acid account for about 70% of unsaturated fatty acid. In particular, polyunsaturated fatty acids contain about 6% of δ-3 α-linolenicacid, which has a preventive effect against heart disease and anti-cancer properties. Unlike milk, cholesterol is not present at all because it is made of soybean. In addition, phospholipid (lecithin), which is effective in preventing senile dementia, reducing cholesterol and neutrophil quality, and improving liver and lipid metabolism disorders, is relatively contained in soy milk. Among the trypsin inhibitors that inhibit protein digestion contained in soybean, 11S globulin is the main constituent protein. Bowman-Brik type is relatively stable to heat, unlike Kunitz type, and maintains its activity during processing. Normal cells are converted into cancer cells It inhibits colon cancer and inhibits breast cancer and oral cancer by inhibiting the necessary protease.
Probiotics와 Prebiotics의 유용한 효과를 동시에 나타내도록 하는 것이 Synbiotics이며 대표적인 것이 Bifidobacterium과 Galacto-oligo 당의 혼합이며, 현재 발효유에 이들이 함께 첨가되어 생산되고 있는 경우가 많은데 이들이 대표적인 Synbiotics라 하겠다. 국내에는 아직까지 Synbiotics의 개념이 정립되지 않아 Probiotics 제품, Prebiotics 제품으로 구분하고 식품공전상 분류명도 아직까지는 혼합유산균으로 사용하고 있다. 최근 Synbiotics 제품들이 생겨나고 있으나, 기존의 유산균제제에 올리고당을 강화한 수준이다.It is Synbiotics that show the beneficial effects of Probiotics and Prebiotics at the same time. A typical example is a mixture of Bifidobacterium and Galacto-oligo sugars, and they are currently produced by adding them together in fermented milk. These are typical Synbiotics. In Korea, the concept of Synbiotics has not yet been established, so it is divided into Probiotics and Prebiotics, and the name of food is still used as mixed lactic acid bacteria. Synbiotics products are emerging, but oligosaccharides are strengthened in existing lactic acid bacteria.
미국 「뉴욕타임스(The New York Times)」는 최근 미국에서 채식(菜食)과 생식(生食)에 이어 면역강화(免疫强化, immunopotentiation) 음식이 대세가 되고 있다고 보도했다. 점점 많은 사람들이 건강의 중요성을 인식하고 면역 체계가 건강한 삶의 토대라는 사실을 인식하기 시작한 것이다.The New York Times reports that food is becoming popular in the United States following vegetarian and raw foods and immunopotentiation. More and more people have begun to recognize the importance of health and recognize that the immune system is the foundation of a healthy life.
최근 마늘, 브로콜리 등 녹황색 채소, 동물성 단백질 및 식물성 단백질, 요구르트, 굴 및 생선, 버섯 및 동충하초, 홍차, 보리, 고구마가 면역력을 높이는데 탁월하다는 보고가 있었다. 면역력을 강화시키는데 단백질과 아연의 공급은 필수 성분이다. 특히 단백질은 외부 병원균이 되는 항원에 대항하는 항체의 주성분이 되기 때문에 단백질이 결핍되면 피부가 약해지고 위나 폐의 점막에 면역성분이 제대로 공급되지 못하여 질병에 걸리게 된다. 호흡기나 소화기 질병에 자주 걸리는 어린이는 바로 단백질의 섭취가 부족하기 때문에 콩 등과 같은 식물성 단백질의 섭취가 면역을 강화시키기 위해서 반드시 필요하다.Recently, it has been reported that green vegetables such as garlic, broccoli, animal protein and vegetable protein, yogurt, oysters and fish, mushroom and cordyceps, black tea, barley and sweet potato are excellent for improving immunity. The supply of protein and zinc is an essential ingredient in enhancing the immune system. In particular, proteins are the main component of antibodies against antigens that act as external pathogens. Therefore, when protein is deficient, the skin becomes weak and the immune component is not properly supplied to the stomach or lung mucosa. Children who are frequently exposed to respiratory or digestive diseases are in short supply of protein, so ingestion of vegetable proteins such as soybeans is essential to enhance immunity.
따라서, 본 발명에서는 친환경 콩에서 가공한 두유와 프로바이오틱스 효능의 유산균을 이용하여 면역강화 효능의 묵 및 그 제조방법을 완성하고자 한다.Therefore, in the present invention, soybean oil processed in eco-friendly soybean and lactobacillus having probiotics efficacy are used to complete a mucilage of immunity-enhancing effect and a preparation method thereof.
본 발명에서는 상기와 같이 대두를 이용하여 두유와 프로바이오틱스 효능의 유산균과 함께 올방개 전분을 주성분으로 하여 소금 등을 첨가하여, 전통적인 맛을 강화하고, 면역효능의 기능이 있는 신규 두유묵 및 그 제조방법을 제공하여, 상기 전통적인 식품의 묵에 대두를 이용하여 다양한 생리적 기능이 있는 두유의 맛과, 프로바이오틱스 효능의 유산균을 첨가하여 면역강화에 도움을 줄 수 있는 묵 및 그 제조방법을 제공하고자 한다.In the present invention, a novel soy milk jelly which has a function of immunity effect by adding soybean oil and probiotics-active lactic acid bacteria and soy sauce starch as a main component and adding salt or the like to soybean milk, To provide a taste of soybean milk having various physiological functions using soybeans in the traditional food jelly, and a jelly which can help immune enhancement by adding lactic acid bacteria of probiotics efficacy, and a preparation method thereof.
본 발명의 상기 목적은 (a) 선별된 대두를 불려 분쇄 후 여과를 통해 두유를 제조하는 공정; (b) 올방개 전분(10~13중량%), 정제수(40~45중량%), 두유액(40~45중량%), 정제소금(0.1~0.2중량%), 유산균을 혼합하여 가열하는 공정; (c) 가열된 혼합액을 여과, 충진 포장하는 공정; (d) 포장된 묵을 X-RAY 이물질을 검출하고 냉장보관하는 단계로 두유 묵을 완성한다. 상기 배합비에 의해 묵을 제조하여 관능검사, 유산균 수 측정, 면역강화 효능을 조사하였다.The above object of the present invention is achieved by a process for producing soybean milk, comprising the steps of: (a) preparing soybean milk by filtering after pulverization by calling selected soybean; (b) a step of mixing and heating lactic acid bacteria (10 to 13 wt%), purified water (40 to 45 wt%), soy milk (40 to 45 wt%), refined salt (0.1 to 0.2 wt% (c) filtering and packing the heated mixed liquid; (d) The step of detecting the X-RAY foreign matter in the packed mackerel and refrigeration is completed. The mushroom was prepared according to the blending ratio, and the sensory test, the number of lactic acid bacteria, and the immunity-enhancing effect were examined.
본 발명은 전통적인 방식의 묵에 대두를 이용하여 두유를 제조하여 첨가하였으며, 맛과 건강을 기대할 수 있으며, 장내 유익균인 유산균을 첨가하여 프로바이오틱스 효능과 면역강화 효능을 증진시킬 수 있는 양질의 전통방식의 묵을 제공하는 효과가 있다. 현재 묵 시장의 대부분의 제품은 전통적인 방식만을 고집하고 있으나, 두유와 유산균을 첨가하여 다른 묵 제품에 비해 효능이 높은 제품이며, 또한 다양한 식물성 원료를 이용한 효용 가치 증대를 기대할 수 있는 제품으로 전통적인 묵 시장을 현대적, 기능성 강화쪽으로 유도할 것으로 기대된다.The present invention relates to a method for producing soybean milk by adding soybean oil to a traditional method of soybean milk, adding flavor and health, and adding a lactic acid bacterium, which is a beneficial bacteria in the intestinal tract, to improve the probiotics efficacy and immunity- It has the effect of providing a jellyfish. Currently, most of the products in the market are sticking to traditional methods, but they are more effective than other jelly products by adding soymilk and lactic acid bacteria, and they can be expected to increase utility value by using various vegetable raw materials. Is expected to lead to modern and functional enhancement.
도 1은 유산균 함량에 따라 제조된 두유 묵의 ABTS 흡광도 값에 대한 그래프이다.
도 2는 유산균 함량에 따라 제조된 두유 묵의 Trolox 비교 그래프이다.
도 3은 유산균 함량에 따라 제조된 두유 묵의 EDA 측정 그래프이다.
도 4는 유산균 함량에 따라 제조된 두유 묵의 총 폴리페놀 흡광도 값에 대한 그래프이다.
도 5는 유산균 함량에 따라 제조된 두유 묵의 Galic acid 비교 그래프이다.
도 6은 유산균 함량에 따라 제조된 두유 묵의 총 플라보노이드 흡광도 값에 대한 그래프이다.
도 7은 유산균 함량에 따라 제조된 두유 묵의 Quercetin 비교 그래프이다.
도 8은 단핵구의 NF-kB 전사인자 활성 측정 결과 그래프이다.
도 9는 단핵구의 TNF-alpha 발현양 측정 그래프이다.
도 10은 NF-kB 활성 측정을 통한 두유묵의 단핵구 면역 조절 기능 확인그래프이다.
도 11은 후보군의 LPS에 의한 단핵구 TNF-alpha 발현양 조절에 대한 그래프이다.Figure 1 is a graph of ABTS absorbance values of soymilk mushrooms prepared according to lactic acid bacteria content.
FIG. 2 is a graph comparing the Trolox of soybean oil mushroom prepared according to the lactic acid bacteria content.
Fig. 3 is a graph of EDA measurement of soybean milk prepared according to lactic acid bacterium content.
4 is a graph of the total polyphenol absorbance value of soybean milk jelly prepared according to the lactic acid bacterium content.
FIG. 5 is a comparative graph of Galic acid of soybean milk prepared according to the content of lactic acid bacteria.
6 is a graph of the total flavonoid absorbance value of soymilk mushroom prepared according to the lactic acid bacterium content.
FIG. 7 is a quercetin comparative graph of soymilk prepared according to the lactic acid bacterium content.
8 is a graph showing the results of measurement of NF-kB transcription factor activity of monocytes.
FIG. 9 is a graph showing the amount of expression of TNF-alpha in monocytes. FIG.
FIG. 10 is a graph showing the mononuclear cell immune regulatory function of soybean milk roots through the measurement of NF-kB activity.
FIG. 11 is a graph showing the modulation of the expression level of monocyte TNF-alpha by the LPS of the candidate group.
본 발명은 식물성 단백질이 풍부한 대두를 이용하여 두유를 제조하고, 유산균을 첨가하여 기능성과 기호성이 향상된 두유 묵 및 그 제조방법을 제공하는데 목적이 있다.It is an object of the present invention to provide a soymilk having improved functionality and palatability by producing soymilk using soybeans rich in vegetable protein and adding lactic acid bacteria, and a method for producing the soymilk.
이하, 본 발명을 실시 예에 따라 더욱 상세하게 설명한다. 그러나 하기 실시 예는 본 발명을 예시하기 위한 것에 불과하므로, 본 발명의 권리범위를 한정하는 것으로 의도 되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to examples. However, the following examples are merely illustrative of the present invention, and are not intended to limit the scope of the present invention.
[실시 예] 두유와 유산균을 이용한 두유 묵 제조[Example] Production of soy milk jelly using soybean milk and lactic acid bacteria
(1) 원료선별 및 두유 제조(1) Selection of raw materials and production of soybean milk
대두는 깨끗한 물에 세척한 후 이물질을 제거하고 정제수를 대두가 잠길 정도(대두:정제수 = 1:2)로 넣어 15~20 시간 불린다. 불린 대두는 한번 거르고, 다시 정제수를 대두 대비 2배로 분쇄기에 넣어 분쇄 후 여과를 통해 두유를 생성한다.The soybeans are cleaned in clean water, and then the debris is removed and the purified water is soaked in soybeans (soybean: purified water = 1: 2) for 15 to 20 hours. Soy beans are filtered once again, and then purified water is pulverized into two times as much as soybeans, and then pulverized and filtered to produce soybean milk.
(2) 원료 혼합 및 가열(2) Raw material mixing and heating
상기 (1)에서 생성된 두유와 정제수, 올방개 전분, 정제소금, 유산균을 표 1의 배합비에 따라 혼합한다. 혼합된 원료는 82~100℃, 30~60분 가열한다.The soy milk and purified water, the starch starch, the purified salt, and the lactic acid bacteria produced in the above (1) are mixed according to the blending ratio shown in Table 1. The mixed raw material is heated at 82 to 100 ° C for 30 to 60 minutes.
(3) 여과, 충진(3) filtration, filling
상기 (2)에서 가열된 원료는 0.4mm 여과망을 통해 여과시키고, 폴리프로필렌 용기에 충진 후, 필름 포장한다.The raw material heated in (2) is filtered through a 0.4 mm filter net, packed in a polypropylene container, and then packaged in a film.
(4) 이물질 검출 및 냉장보관(4) Detecting foreign matter and refrigerated
상기 (3)에서 포장된 묵은 X-RAY 검출기를 통하여 금속(Fe, Sus) 2.0mm 이상 불검출로 이물질을 검출하고 지대박스의 냉장온도 0~10℃에서 냉장하여 두유 묵을 완성한다.The foreign substance is detected by not detecting metal (Fe, Sus) more than 2.0 mm through the old X-RAY detector packaged in (3) and refrigerated at 0 ~ 10 ℃ in the zone box to complete the soy milk paste.
* 두유는 10.5~11.5 Brix* Soy milk is 10.5 ~ 11.5 Brix
* 유산균은 1g 당 7조 5천억마리* Lactic acid bacteria, 7.5g per gram,
[실험예 2] 두유와 유산균을 이용한 두유 묵의 관능평가[Experimental Example 2] Sensory evaluation of soybean milk jelly using soybean milk and lactic acid bacteria
상기 실시 예인 두유와 유산균을 이용한 두유 묵에 대한 관능평가는 배합비 별로 제조된 묵을 패널 10명을 통해 실시하였다. 관능 평가항목은 맛, 향, 식감 및 종합기호도에 대해 5점 척도를 기준으로 5점은 ‘매우 좋음’, 4점 ‘좋음’, 3점 ‘보통’, 2점 ‘나쁨’, 1점은 ‘매우 좋지않음’으로 평가하였고 그 결과를 표 2에 나타내었다.The sensory evaluation of soymilk mushroom using soybean milk and lactic acid bacterium according to the above example was carried out through ten panelists of mushroom prepared according to the blending ratio. The sensory evaluation items were 5 points for 'taste', 4 points for 'good', 3 points for 'normal', 2 points for 'poor', 1 point for 'taste', ' Very poor 'and the results are shown in Table 2.
[실험예 3] 두유와 유산균을 이용한 두유 묵의 유산균 수 측정[Experimental Example 3] Measurement of the number of lactic acid bacteria in soybean milk jelly using soybean milk and lactic acid bacteria
상기 실시 예에 따라 유산균 0, 100%, 200%, 400%, 800%를 포함시켜 두유 묵을 제조하고, Rapid microbial cell counter으로 제조된 두유 묵에 유산균 수를 측정하였다.Soymilk jelly was prepared by including 0%, 100%, 200%, 400%, and 800% of lactic acid bacteria according to the above examples, and the number of lactic acid bacteria was measured in a soybean milk jelly made with a rapid microbial cell counter.
유산균 함량에 따른 두유 묵 1g에는 각각 0, 9.7×107 Cells/g, 2.0×108 Cells/g, 4.0×108 Cells/g, 8.2×108 Cells/g 포함되어 있다고 판단되어진다.It is judged that 1 g of soybean milk jam according to the lactic acid bacteria content contains 0, 9.7 × 10 7 Cells / g, 2.0 × 10 8 Cells / g, 4.0 × 10 8 Cells / g and 8.2 × 10 8 Cells / g, respectively.
(Cells/ml)Actual number of bacteria
(Cells / ml)
(Cells/g)Number of lactic acid bacteria
(Cells / g)
[실험예 4] 두유와 유산균을 이용한 두유 묵의 ABTS 측정[Experimental Example 4] ABTS measurement of soybean milk jelly using soybean milk and lactic acid bacteria
상기 실시 예에 따라 제조된 두유 묵의 ABTS는 두유 묵 6g과 24 mL의 증류수를 멸균팩에 넣고 균질화한 후 40℃에서 5분간 sonication 한 후, 3,000 rpm에서 10분간 원심분리하여 상층액을 얻어 두유 묵 추출물로 하였다. 7.4 mM ABTS 용액과 2.6 mM potassium persulphate을 혼합하여 암소에서 약 15시간 이상 암소에서 반응시킨 후 spectophometer (UV-2450P, Shimadzu, Korea)을 이용하여 414 nm에서 흡광도가 1.5가 되도록 희석하였다. 희석한 용액 10 mL에 각 농도별 조제한 추출물 1 mL를 첨가하여 10초간 진탕하고 실온에서 90분간 방치한 다음 414 nm에서 흡광도를 측정하였다. 한편, ascorbic acid를 임의의 농도로 조제하여 동일한 방법으로 흡광도를 측정함으로써 비교하였다. 시료의 환원력은 trolox를 이용하여 만든 표준곡선에 대입하여 시료 중 100 g에 해당하는 trolox의 용량(mg)으로 표시하였다.The soymilk ABTS prepared according to the above example was prepared by homogenizing 6 g of soybean milk jelly and 24 mL of distilled water in a sterilized pack, sonicating at 40 ° C for 5 minutes, centrifuging at 3,000 rpm for 10 minutes to obtain supernatant, Respectively. 7.4 mM ABTS solution and 2.6 mM potassium persulphate were mixed in a dark place for 15 hours in a dark place and diluted to a absorbance of 1.5 at 414 nm using a spectrophotometer (UV-2450P, Shimadzu, Korea). To 10 mL of the diluted solution was added 1 mL of the extract prepared at each concentration, shaken for 10 seconds, allowed to stand at room temperature for 90 minutes, and then absorbance was measured at 414 nm. On the other hand, ascorbic acid was prepared at an arbitrary concentration and the absorbance was measured by the same method. The reducing power of the sample was expressed as the dose (mg) of trolox equivalent to 100 g in the sample by substituting into the standard curve made using trolox.
[실험예 5] 두유와 유산균을 이용한 두유 묵의 DPPH 측정[Experimental Example 5] DPPH measurement of soybean milk jelly using soybean milk and lactic acid bacteria
상기 실시 예에 따라 제조된 두유 묵의 DPPH에 대한 전자공여능을 통한 항산화 활성은 두유 묵 6g과 24 mL의 증류수를 멸균팩에 넣고 균질화한 후 40℃에서 5분간 sonication 한 후, 3,000 rpm에서 10분간 원심분리하여 상층액을 얻어 두유 묵 추출물로 하였다. 추출물 1 mL에 0.4 mM DPPH 9 mL를 가하고 10초간 혼합한 후 암소에서 30분간 반응시키고 shimadzu UV-2450P Spectrophometer을 이용하여 517 nm 파장에서 흡광도를 측정하였다. 음성대조군은 시료대신 에탄올을 동량 첨가하여 실험하였고(공시험), 양성대조군으로는 BHT 시약을 이용하여 동일한 방법으로 실시하였다. EDA(%)는 시료첨가구와 무첨가구의 흡광도 값을 구하여 다음 식으로 계산하여 백분율로 표시하였다.The antioxidative activity of DPPH prepared according to the above example was determined by homogenizing 6 g of soybean paste and 24 mL of distilled water in sterilized pack, sonication at 40 ° C for 5 minutes, centrifuging at 3,000 rpm for 10 minutes The supernatant was separated and used as a soybean oil extract. 9 mL of 0.4 mM DPPH was added to 1 mL of the extract, mixed for 10 seconds, reacted for 30 minutes in a dark place, and absorbance was measured at a wavelength of 517 nm using a shimadzu UV-2450P spectrophometer. In the negative control group, ethanol was added in the same amount (blank test) instead of the sample, and BHT reagent was used as the positive control group. The EDA (%) was calculated by the following formula and expressed as a percentage.
[실험예 6] 두유와 유산균을 이용한 두유 묵의 총 폴리페놀 측정[Experimental Example 6] Total polyphenol measurement of soybean milk jelly using soybean milk and lactic acid bacteria
상기 실시 예에 따라 제조된 두유 묵의 Polyphenol 함량은 두유 묵 시료 4 mL에 1N Folin-Ciocalteu reagent 4 mL를 가하였다. 실온에서 5분 반응시킨 다음 알칼리 조건을 형성하기 위해 10% Na2CO3 4 mL를 가하여 2시간 방치한 후 spectrophometer (UV-2450P, Shimadzu, Korea)을 이용하여 반응액의 흡광도를 725 nm에서 측정하였다. 표준물질로는 Gallic acid를 단계별로 희석하여 표준곡선을 작성하고 결과를 산출하였다.Polyphenol content of soybean milk jelly prepared according to the above example was 4 mL of 1N Folin-Ciocalteu reagent in 4 mL of soy milk jelly sample. After incubation at room temperature for 5 minutes, 4 mL of 10% Na 2 CO 3 was added to the reaction mixture for 2 hours, and the absorbance of the reaction solution was measured at 725 nm using a spectrophotometer (UV-2450P, Shimadzu, Korea) Respectively. As a standard material, Gallic acid was diluted stepwise to create a standard curve and the results were calculated.
[실험예 7] 두유와 유산균을 이용한 두유 묵의 총 플라보노이드 측정[Experimental Example 7] Total flavonoid measurement of soybean milk jelly using soybean milk and lactic acid bacteria
상기 실시 예에 따라 제조된 두유 묵의 총 Flavonoid 함량은 시료는 두유 묵 6g과 24 mL의 증류수를 멸균팩에 넣고 균질화한 후 40℃에서 5분간 sonication 한 후, 3,000 rpm에서 10분간 원심분리하여 상층액을 얻어 대두유묵 추출물로 하였다. 추출물 1 mL에 1N NaOH 1 mL와 diethyl glycol 10 mL 혼합액을 가하여 실온에 방치하여 1시간 반응시킨 다음 spectrophometer (UV-2450P, Shimadzu, Korea)을 이용하여 반응액의 흡광도를 420 nm에서 측정하였다. 표준물질로는 Quercetin을 단계별로 희석하여 표준곡선을 작성하고 결과를 산출하였다.The total flavonoid content of the soybean milk jelly prepared according to the above example was obtained by homogenizing 6 g of soybean milk jelly and 24 mL of distilled water in sterilized pack, sonication at 40 ° C for 5 minutes, centrifuging at 3,000 rpm for 10 minutes, To obtain a soybean oyster extract. To 1 mL of the extract, 1 mL of 1N NaOH and 10 mL of diethyl glycol was added and allowed to react at room temperature for 1 hour. The absorbance of the reaction solution was measured at 420 nm using a spectrophotometer (UV-2450P, Shimadzu, Korea). Quercetin was diluted stepwise as a reference material and a standard curve was created and the results were calculated.
[실험예 8] 두유 묵의 단핵구 내 NF-kB 전사인자 활성 측정[Experimental Example 8] Measurement of NF-kB transcription factor activity in monocyte of soybean milk
두유묵 시제품 대상으로 면역 활성에 중요하게 작용하는 cytokine 유전자들의 발현을 조절하는 전사인자 중 주요 인자로 알려진 NF-kB의 활성을 reporter assay를 통해 단핵구 면역 연구에 흔히 쓰이는 세포주 중 하나인 Raw264.7 세포에서 확인하였다.The activity of NF-kB, a major factor in the transcription factors regulating the expression of cytokine genes important for immunoactivity, was investigated in reporter assays using Raw264.7 cells, one of the cell lines commonly used for monocyte immunoassay Respectively.
단핵구에 NF-kB reporter plasmid를 transfection 후 48 시간이 지난 시간에 LPS 및 후보 두유묵을 12시간 처리 후, luciferase activity 측정하였다.The luciferase activity was measured after 48 hours of transfection of the NF-kB reporter plasmid into monocytes and after 12 hours of treatment with LPS and candidate soybean milk.
양성대조군으로 lipopolysaccaride(LPS)를 처리하여 면역 작용의 대표적 전사인자 중 하나인 NF-kB의 전사인자 활성을 비교 측정하였다. 후보 두유묵의 활성이 매우 높게 나타났으며 후보 두유묵은 LPS보다도 활성을 높였다. 이 결과는 후보 두유묵은 단핵구의 면역 활성에 영향을 미친다는 결론을 얻었다.As a positive control, lipopolysaccaride (LPS) was treated to measure the transcription factor activity of NF-kB, one of the typical transcription factors of immune function. The activity of candidate soybean milk jelly was very high, and the activity of soybean milk jelly was higher than that of LPS. We conclude that this result influences the immunological activity of the candidate soybean milk monocytes.
[실험예 9] 두유 묵의 TNF-alpha 발현 측정[Experimental Example 9] Expression of TNF-alpha in soybean milk
면역 조절 NF-kB 전사인자에 의해 영향을 받는 cytokine들 중 잘 알려진 것 중 하나가 TNF-alpha이다. 따라서, 단핵구에 LPS 및 후보 두유묵을 12시간 처리 후 TNF-alpha 발현 정도를 배양액을 모은 후에 ELISA를 통해 측정하였다.One of the well-known cytokines affected by immunomodulating NF-kB transcription factors is TNF-alpha. Therefore, the level of TNF-alpha expression was measured by ELISA after collecting the culture medium after treatment with LPS and candidate soymilk for 12 hours.
ELISA를 통해 TNF-alpha의 농도를 측정 결과, LPS는 알려진 것처럼 TNF-alpha 분비를 증가시켰으며, 이는 NF-kB 전사인자 활성에 의한 것임을 알 수 있다. 후보 두유묵을 처리 시에 NF-kB 전사인자 활성과 매우 유사하게 후보 두유묵이 TNF-alpha 발현을 증가시키는 것으로 나타났으며, 후보 두유묵은 LPS와 비슷한 정도로 TNF-alpha을 증가시키는 것으로 나타났다. 따라서, 본 연구 결과를 통해, 후보 두유묵은 면역 활성에 영향을 줄 것으로 기대하며, 후보 두유 묵의 경우 매우 탁월한 효과를 보인다. As a result of measuring the concentration of TNF-alpha by ELISA, LPS increased TNF-alpha secretion as known, which is due to NF-kB transcription factor activity. The candidate soybean milk mousses showed an increase in TNF-alpha expression, similar to NF-kB transcription factor activity in the treatment of candidate soy milk, and the candidate soybean milk jelly increased TNF-alpha to a similar degree as LPS. Therefore, the results of this study suggest that the candidate soymilk is expected to affect the immune activity, and the candidate soymilk mushroom is very effective.
[실험예 10] 두유 묵의 단핵구 내 NF-kB 전사인자 활성 측정[Experimental Example 10] Measurement of NF-kB transcription factor activity in monocyte of soybean milk
두유 묵 시제품 대상으로 면역 조절 기능에 중요하게 작용하는 cytokine 유전자들의 발현을 조절하는 전사인자 중 주요 인자로 알려진 NF-kB의 활성을 reporter assay를 통해 단핵구 면역 연구에 흔히 쓰이는 세포주 중 하나인 Raw264.7 세포에서 확인한다. 단핵구에 NF-kB reporter plasmid를 transfection 후 48 시간이 지난 시간에 LPS 단독 또는 LPS와 후보 두유묵을 12시간 처리. 이후 luciferase activity 측정하였다.The activity of NF-kB, a major factor in the transcription factors regulating the expression of cytokine genes important for immuno-regulatory functions, was investigated by reporter assay using Raw264.7, a cell line commonly used for monocyte immunoassay Identify in cells. After transfection of NF-kB reporter plasmid into mononuclear cells, LPS alone or LPS and candidate soymilk were treated 12 hours after 48 hours. The luciferase activity was then measured.
LPS에 의한 단핵구 면역 활성 증가를 NF-kB 활성 수준으로 확인하였으며, 두유 묵 후보군을 함께 처리한 경우 LPS에 의한 NF-kB 활성은 줄어드나, 대조군과 비교 시 여전히 증가하기 때문에 면역 활성 기능은 유지하는 것으로 보인다.The increase in monocyte immunity by LPS was confirmed to be the level of NF-kB activity, and the NF-kB activity by LPS was decreased when the soybean oil candidate group was treated together, but still increased in comparison with the control group. Seems to be.
[실험예 11] 두유 묵의 TNF-alpha 발현 측정[Experimental Example 11] Expression of TNF-alpha in soybean milk
면역 조절 NF-kB 전사인자에 의해 영향을 받는 cytokine들 중 잘 알려진 것 중 하나가 TNF-alpha이다. 따라서, 단핵구에 LPS 및 두 후보 두유묵을 12시간 처리 후 TNF-alpha 발현 정도를 배양액을 모은 후에 ELISA를 통해 측정하였다.One of the well-known cytokines affected by immunomodulating NF-kB transcription factors is TNF-alpha. Therefore, the level of TNF-alpha expression was measured by ELISA after collecting the culture medium after treatment with LPS and two candidate soybean milk for 12 hours.
LPS를 단독으로 처리 시 TNF-alpha의 발현양은 증가하였으나, 후보군과 함께 처리 시에는 LPS 단독 처리시에 미치지 못하나, 대조군과 비교 시에 여전히 증가한 TNF-alpha 발현양을 보인다.The expression of TNF-alpha was increased when treated with LPS alone, but not with LPS alone when treated with the candidate group, but still increased with TNF-alpha compared with the control group.
본 발명은 두유와 유산균을 함유한 면역강화 효능의 묵 및 그 제조방법에 관한 것으로 전통적인 방식의 묵에 대두를 이용하여 두유를 제조하여 첨가하였으며, 맛과 건강을 기대할 수 있으며, 장내 유익균인 유산균을 첨가하여 프로바이오틱스 효능과 면역강화 효능을 증진시킬 수 있는 양질의 전통방식의 묵을 제공하여 국내 전통 묵 시장에 두유 묵을 제공하여 전통 묵 시장을 현대적, 기능성 묵 시장으로 확대시킬 수 있어 식품산업 측면에서 매우 유용한 발명이다.The present invention relates to an immunocompromising mucilage containing soybean milk and lactic acid bacteria, and a method for preparing the same. Soybean milk is prepared by adding soybean milk to a conventional mucilage, and taste and health can be expected. It is very useful in the aspect of food industry because it can provide traditional Korean mushroom market by providing good quality traditional mushroom which can enhance probiotics efficacy and immunity strengthening effect. Invention.
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170181976A KR20190079899A (en) | 2017-12-28 | 2017-12-28 | Jellied food with Immune Enhancing Effect Containing Soy Milk and Lactic Acid Bacteria and Its Preparation Method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170181976A KR20190079899A (en) | 2017-12-28 | 2017-12-28 | Jellied food with Immune Enhancing Effect Containing Soy Milk and Lactic Acid Bacteria and Its Preparation Method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190079899A true KR20190079899A (en) | 2019-07-08 |
Family
ID=67256054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170181976A KR20190079899A (en) | 2017-12-28 | 2017-12-28 | Jellied food with Immune Enhancing Effect Containing Soy Milk and Lactic Acid Bacteria and Its Preparation Method |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190079899A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210156960A (en) * | 2020-06-19 | 2021-12-28 | 윤병기 | Gel-type health food and its manufacturing method using seaweed and kelp |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100487885B1 (en) | 2003-01-13 | 2005-05-06 | (주)행림원 | a |
-
2017
- 2017-12-28 KR KR1020170181976A patent/KR20190079899A/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100487885B1 (en) | 2003-01-13 | 2005-05-06 | (주)행림원 | a |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20210156960A (en) * | 2020-06-19 | 2021-12-28 | 윤병기 | Gel-type health food and its manufacturing method using seaweed and kelp |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6869621B2 (en) | Diet composition comprising raw foods and dietary fibers | |
KR101107848B1 (en) | Functional noodle for aged people and manufacturing method thereof | |
JP2008174539A (en) | Healthy and functional food for obesity patient using purple-colored potato | |
CN100426989C (en) | Fat-reducing nutrient instant food and making method thereof | |
JP3644500B2 (en) | Method for producing mushroom lactic acid fermented liquid and mushroom lactic acid fermented liquid produced therefrom | |
KR102305931B1 (en) | A food composition for improving circulation of blood and increasing functions of immune comprising natural extracts | |
CN105010477A (en) | Moringa oleifera biscuit and preparation method thereof | |
Murevanhema | Evaluation of bambara groundnuts (Vigna subterrenea (L.) Verdc.) milk fermented with lactic acid bacteria as a probiotic beverage | |
KR20190079899A (en) | Jellied food with Immune Enhancing Effect Containing Soy Milk and Lactic Acid Bacteria and Its Preparation Method | |
KR20140083507A (en) | Salad dressing comprising mulberry and method for preparing the same | |
KR20030089967A (en) | The preparation method of anti-allergic and hypoallergic fermented soybean foods | |
KR101558134B1 (en) | Soybean paste and method for preparing the same | |
KR101887122B1 (en) | Method for preparing functional noodle comprising auricularia auricula judae and functional noodle prepared thereof | |
CN106256237A (en) | Sweet-scented cake | |
KR101403593B1 (en) | Yogurt comprising barley and preparation method thereof | |
KR20170055356A (en) | soybean meat containing large quantity of conjugated linoleic acid and isoflavone and manufacturing method thereof | |
KR101144753B1 (en) | Method for producing noodles using tangle, radish leaves and soybean paste and noodles produced by the same | |
KR100880817B1 (en) | The hot sauce containing medicinal herbs | |
KR20050045666A (en) | Composition for inhibiting of obesity | |
WO2020018050A2 (en) | A natural, nutrituous and a delicious gluten-free functional food with protective and supportive effects on health and its production method | |
KR20190110058A (en) | The method for manufacturing a yomena aster cookie, and the yomena aster cookie manufactured by the method | |
Asrat | Promoting Home Prepared Soy-dishes for Fighting Protein-Energy Malnutrition: Evidence from Demonstration Training | |
CN108272083A (en) | A kind of nutritious food packet having for meal effect | |
KR102349905B1 (en) | Dietary food composition consisting of pumpkin, bellflower and apple with excellent customer satisfaction | |
KR102549244B1 (en) | Manufacturing method of hallabong bread and hallabong bread manufactured by the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |